CAR T Therapy Clears Liver Cancer in 3-Year-Old: CARE Study
A new NEJM case report describes complete regression of chemotherapy-resistant hepatoblastoma in a 3-year-old after two outpatient CAR T cell
Useful takeaways from this story.
A new NEJM case report describes complete regression of chemotherapy-resistant hepatoblastoma in a 3-year-old after two outpatient CAR T cell
Building the complete brief
The page is ready to read now. The fuller skim-friendly version will appear here automatically.
The useful part
A new NEJM case report describes complete regression of chemotherapy-resistant hepatoblastoma in a 3-year-old after two outpatient CAR T cell
Keep reading in the app
Open the app view to save this story, compare related coverage, and continue from the same source.